Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Jones

Showing results (351-360 of 3,661) with videos related to

Pageof 367
Sort By:
Journal of the American Pharmacists Association : Japha|May 19, 2007
Therapeutic rationale of combining therapy with gemfibrozil and simvastatinPatrick O Curtin, William N Jones
Antimicrobial Agents and Chemotherapy|April 1, 1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)R N Jones, A L Barry
Journal of Clinical Microbiology|April 1, 1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|February 8, 2003
Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinoneTamara R Anderegg, Ronald N Jones,
Expert Opinion on Therapeutic Targets|January 31, 2003
Analysing p53 tumour suppressor functions in miceHayla K Sluss, Stephen N Jones
International Psychogeriatrics|January 5, 2002
Education bias in the mini-mental state examinationR N Jones, J J Gallo
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 2, 2000
Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugsM T Lewis, R N Jones
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Fluoroquinolones for the treatment of outpatient community-acquired pneumoniaRonald N Jones, Lionel A Mandell
The Journal of Membrane Biology|April 23, 1975
D-glucose permeability of black lipid membranes modified by human erythrocyte membrane fractionsG P Lidgard, M N Jones
Diagnostic Microbiology and Infectious Disease|May 6, 2003
Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000)Kelley A Gordon, Ronald N Jones,
Pageof 367

Showing results (351-360 of 3,661) with videos related to

Sort By:
Pageof 367
Journal of the American Pharmacists Association : Japha|May 19, 2007
Therapeutic rationale of combining therapy with gemfibrozil and simvastatinPatrick O Curtin, William N Jones
Antimicrobial Agents and Chemotherapy|April 1, 1988
Antimicrobial activity and disk diffusion susceptibility testing of U-76,253A (R-3746), the active metabolite of the new cephalosporin ester, U-76,252 (CS-807)R N Jones, A L Barry
Journal of Clinical Microbiology|April 1, 1988
Disk diffusion susceptibility testing for LY163892 (KT-3777), a new orally administered 1-carbacephemR N Jones, A L Barry
Diagnostic Microbiology and Infectious Disease|February 8, 2003
Determination of disk diffusion and MIC quality control parameters for AZD2563, a novel long-acting oxazolidinoneTamara R Anderegg, Ronald N Jones,
Expert Opinion on Therapeutic Targets|January 31, 2003
Analysing p53 tumour suppressor functions in miceHayla K Sluss, Stephen N Jones
International Psychogeriatrics|January 5, 2002
Education bias in the mini-mental state examinationR N Jones, J J Gallo
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|May 2, 2000
Activity of macrolides, lincosamines, streptogramins and fluoroquinolones against streptococcus pneumoniae and enterococci isolates from the western hemisphere: example of international surveillance (SENTRY antimicrobial surveillance program )in the development of new drugsM T Lewis, R N Jones
Diagnostic Microbiology and Infectious Disease|October 12, 2002
Fluoroquinolones for the treatment of outpatient community-acquired pneumoniaRonald N Jones, Lionel A Mandell
The Journal of Membrane Biology|April 23, 1975
D-glucose permeability of black lipid membranes modified by human erythrocyte membrane fractionsG P Lidgard, M N Jones
Diagnostic Microbiology and Infectious Disease|May 6, 2003
Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000)Kelley A Gordon, Ronald N Jones,
Pageof 367